Bioequivalence of alternative pembrolizumab dosing regimens: current practice and future perspectives.

{"title":"Bioequivalence of alternative pembrolizumab dosing regimens: current practice and future perspectives.","authors":"Ruben Malmberg, Bram C Agema, Maaike M Hofman, Stefani Oosterveld, Sander Bins, Daphne W Dumoulin, Arjen Joosse, Joachim G J V Aerts, Reno Debets, Birgit C P Koch, Astrid A M van der Veldt, Roelof W F van Leeuwen, Ron H J Mathijssen","doi":"10.1002/cac2.12661","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":9495,"journal":{"name":"Cancer Communications","volume":" ","pages":""},"PeriodicalIF":20.1000,"publicationDate":"2025-01-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer Communications","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1002/cac2.12661","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}